More stories below advertisement
Latest Press Releases
WeedMD Announces the Development of New Cannabis 2.0 Products Featuring Hash, Live Resin and Rosin Extracts for Adult-Use Lineup
- GlobeNewswire - Tue Jan 19, 7:06AM CST
GlobeNewswire - CMTX
Tue Jan 19, 7:06AM CST
WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) ("WeedMD" or the "Company"), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce it is kicking off 2021 with the development of new extract products featuring live resin and solventless hash, and rosin concentrates. The Company's newest Cannabis 2.0 extract products are expected to debut during the second quarter of 2021, under WeedMD's Color Cannabis and Saturday Cannabis adult-use brands.
WeedMD Expands its Color Cannabis Brand into the Province of Quebec
- GlobeNewswire - Thu Jan 14, 7:02AM CST
GlobeNewswire - CMTX
Thu Jan 14, 7:02AM CST
WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) ("WeedMD" or the "Company"), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce the expansion of its adult-use brand Color Cannabis into the province of Quebec. WeedMD entered into a sales, marketing and distribution agreement with Quebec-based cultivator ROSE LifeScience Inc. ("ROSE") to bring the Company's adult-use products to consumers in Quebec through the Societe quebecoise du cannabis ("SQDC") commencing in early 2021.
WeedMD Consolidates Medical Distribution Activities and Closes Facility to Maximize Production Efficiencies
- GlobeNewswire - Thu Jan 7, 7:05AM CST
GlobeNewswire - CMTX
Thu Jan 7, 7:05AM CST
WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) ("WeedMD" or the "Company"), a federally licensed producer and distributor of medical-grade cannabis, announced today it has reallocated all medical packaging, labelling and distribution activities from its Bowmanville, Ontario site to its Aylmer, Ontario facility which also houses the Company's extraction hub. These strategic steps are part of WeedMD's ongoing plan to maximize the utilization of its facilities, improve operational efficiencies and further align its cost structure while focusing on growth, following the successful integration of WeedMD and Starseed Holdings Inc. ("Starseed").
WeedMD Posts New Year Shareholder Newsletter From Interim CEO
- GlobeNewswire - Wed Jan 6, 9:31AM CST
GlobeNewswire - CMTX
Wed Jan 6, 9:31AM CST
WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) ("WeedMD" or the "Company"), a federally-licensed producer and distributor of medical-grade cannabis, announced today that Executive Chairman and Interim Chief Executive Officer George Scorsis issued an open letter to shareholders to provide a corporate overview of WeedMD's operational and commercial activities. The Company confirmed it kicks off 2021 having doubled revenues in 2020 and fully ramped-up its quality cultivation and production platform.
WeedMD Announces CEO Leadership Transition and New Board Appointment
- GlobeNewswire - Mon Jan 4, 8:10AM CST
GlobeNewswire - CMTX
Mon Jan 4, 8:10AM CST
WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) ("WeedMD" or the "Company"), a federally-licensed producer and distributor of medical-grade cannabis, announced today that its board of directors (the "Board") has appointed executive chairman, George Scorsis, as interim Chief Executive Officer, effective immediately. This appointment follows Angelo Tsebelis's decision to step down from his CEO and director roles, with mutual agreement from the Board, following the successful year-long integration of WeedMD and Starseed Holdings Inc. ("Starseed"). Mr. Tsebelis has agreed to take an advisory role to help the Company through this period of transition.
WeedMD Launches Terpene-Infused Saturday Cannabis-branded Vaporization Products
- GlobeNewswire - Thu Dec 17, 7:18AM CST
GlobeNewswire - CMTX
Thu Dec 17, 7:18AM CST
WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) ("WeedMD" or the "Company"), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce it is expanding its Cannabis 2.0 product portfolio with the launch of its new one-gram, 510-thread vaporization ("vape") products in Ontario, to be sold under its Saturday Cannabis ("Saturday") branded line-up.
WeedMD's Color Cannabis Brand Selected as Top Sativa Flower for "Pedro's Sweet Sativa" at Inaugural Kind Magazine Awards
- GlobeNewswire - Thu Dec 10, 6:30AM CST
GlobeNewswire - CMTX
Thu Dec 10, 6:30AM CST
WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) ("WeedMD" or the "Company"), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce its Color Cannabis cultivar, Pedro's Sweet Sativa, was awarded Top Sativa Flower in Canada. Chosen by over 150 retail budtenders from across the country, the awards were organized by KIND Magazine, Canada's pre-eminent premium cannabis lifestyle magazine.
WeedMD Debuts New Color Cannabis Cultivar Black Sugar Rose in Ontario and Launches Terpene-Labelled Profiles
- GlobeNewswire - Mon Dec 7, 8:19AM CST
GlobeNewswire - CMTX
Mon Dec 7, 8:19AM CST
-- Acclaimed strain released via the Ontario Cannabis Store with other provinces coming soon
WeedMD Reports Third Quarter 2020 Financial Results
- GlobeNewswire - Tue Dec 1, 11:21AM CST
GlobeNewswire - CMTX
Tue Dec 1, 11:21AM CST
WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) ("WeedMD" or the "Company"), a federally-licensed producer and distributor of medical-grade cannabis, announced today its financial results for the three and nine months ended September 30, 2020.
WeedMD Expands Starseed Medicinal Access to Atlantic Canada Alongside Leading Cannabis Physician and Advocate Dr. Julie Hildebrand
- GlobeNewswire - Thu Nov 26, 6:31AM CST
GlobeNewswire - CMTX
Thu Nov 26, 6:31AM CST
WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) ("WeedMD" or the "Company"), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce it has expanded its North Star Wellness Virtual Patient Care Program and access to its Starseed Medicinal products to Atlantic Canada under the purview of New Brunswick-based physician, Dr. Julie Hildebrand.
More stories below advertisement